Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cognition Therapeutics Inc (CGTX)

Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cognition Therapeutics Announces Promising Phase 2 Results for CT1812 in Dementia with Lewy Bodies, Plans Advancement to Late-Stage Trials Quiver Quantitative, Inc. - Wed Dec 18, 4:36PM CST

Cognition Therapeutics announces promising Phase 2 trial results for CT1812 in dementia with Lewy bodies, with plans for late-stage trials.Quiver AI SummaryCognition Therapeutics, Inc. announced promising...

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies GlobeNewswire - Wed Dec 18, 6:22AM CST

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics Announces all Participants have Completed their Final Visits in the Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies GlobeNewswire - Tue Nov 26, 6:30AM CST

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics, Inc. Reports 95% Reduction in Cognitive Decline in Alzheimer’s Patients Treated with CT1812 in Phase 2 SHINE Study Quiver Quantitative, Inc. - Mon Nov 25, 4:48PM CST

CT1812 treatment shows a 95% reduction in cognitive decline and improvement in Alzheimer’s biomarkers in Phase 2 study.Quiver AI SummaryCognition Therapeutics, Inc. announced significant findings from...

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics’ Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer’s Population GlobeNewswire - Mon Nov 25, 6:30AM CST

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update GlobeNewswire - Wed Nov 13, 6:30AM CST

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum GlobeNewswire - Tue Nov 12, 6:30AM CST

CGTX : 0.6301 (-0.62%)
Author
November’s Small-Cap Treasures: 3 Stocks Poised for Growth MarketBeat - Mon Nov 4, 6:45AM CST

Three promising small-cap stocks, poised for growth in healthcare, cybersecurity, and renewable energy, offer compelling investment opportunities for November.

LODE : 0.3371 (+11.81%)
CGTX : 0.6301 (-0.62%)
ASNS : 1.0300 (+0.98%)
Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD GlobeNewswire - Thu Oct 31, 3:15PM CDT

CGTX : 0.6301 (-0.62%)
Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD GlobeNewswire - Tue Oct 29, 11:55AM CDT

CGTX : 0.6301 (-0.62%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 1 hour ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot